Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 462

1.

Geographical variations in the incidence of oesophageal cancer in Sweden.

Xie SH, Mälberg K, Andersson G, Lagergren J.

Scand J Gastroenterol. 2020 Feb 11:1-7. doi: 10.1080/00365521.2020.1724322. [Epub ahead of print]

PMID:
32045532
2.

Aspiration pneumonia after antireflux surgery among neurologically impaired children with GERD.

Maret-Ouda J, Santoni G, Artama M, Ness-Jensen E, Svensson JF, von Euler-Chelpin M, Lagergren J.

J Pediatr Surg. 2020 Jan 10. pii: S0022-3468(19)30934-0. doi: 10.1016/j.jpedsurg.2019.12.024. [Epub ahead of print]

PMID:
32037217
3.

Influence of socioeconomic status on immediate breast reconstruction rate, patient information and involvement in surgical decision-making.

Frisell A, Lagergren J, Halle M, de Boniface J.

BJS Open. 2020 Jan 31. doi: 10.1002/bjs5.50260. [Epub ahead of print]

4.

Complications after pressure ulcer surgery - a study of 118 operations in spinal cord injured patients.

Lindqvist EK, Sommar P, Stenius M, Lagergren JF.

J Plast Surg Hand Surg. 2020 Jan 31:1-6. doi: 10.1080/2000656X.2020.1720700. [Epub ahead of print]

PMID:
32003279
5.

Hospital Volume of Antireflux Surgery in Relation to Endoscopic and Surgical Re-interventions.

Markar S, Santoni G, Maret-Ouda J, Artama M, Färkkilä M, Lynge E, Pukkala E, Ness-Jensen E, von Euler-Chelpin M, Lagergren J.

Ann Surg. 2020 Jan 6. doi: 10.1097/SLA.0000000000003776. [Epub ahead of print]

PMID:
31913870
6.

Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus.

Knight WRC, Yip C, Wulaningsih W, Jacques A, Griffin N, Zylstra J, Van Hemelrijck M, Maisey N, Gaya A, Baker CR, Kelly M, Gossage JA, Lagergren J, Landau D, Goh V, Davies AR; Guy's and St Thomas' Oesophago‐Gastric Research Group, Ngan S, Qureshi A, Deere H, Green M, Chang F, Mahadeva U, Gill-Barman B, George S, Dunn J, Zeki S, Meenan J, Hynes O, Tham G, Iezzi C.

BJS Open. 2019 Aug 22;3(6):767-776. doi: 10.1002/bjs5.50211. eCollection 2019 Dec.

7.

Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study.

Wang QL, Santoni G, Ness-Jensen E, Lagergren J, Xie SH.

Am J Gastroenterol. 2020 Jan;115(1):73-78. doi: 10.14309/ajg.0000000000000478.

PMID:
31821177
8.

Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.

Maret-Ouda J, Santoni G, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J.

Ann Surg. 2019 Nov 27. doi: 10.1097/SLA.0000000000003709. [Epub ahead of print]

PMID:
31800492
9.

Colon and rectal cancer risk after bariatric surgery in a multicountry Nordic cohort study.

Tao W, Artama M, von Euler-Chelpin M, Hull M, Ljung R, Lynge E, Ólafsdóttir GH, Pukkala E, Romundstad P, Talbäck M, Tryggvadottir L, Lagergren J.

Int J Cancer. 2019 Dec 3. doi: 10.1002/ijc.32770. [Epub ahead of print]

PMID:
31797382
10.

Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Xie SH, Fang R, Huang M, Dai J, Thrift AP, Anderson LA, Chow WH, Bernstein L, Gammon MD, Risch HA, Shaheen NJ, Reid BJ, Wu AH, Iyer PG, Liu G, Corley DA, Whiteman DC, Caldas C, Pharoah PD, Hardie LJ, Fitzgerald RC, Shen H, Vaughan TL, Lagergren J.

Clin Gastroenterol Hepatol. 2019 Nov 19. pii: S1542-3565(19)31317-5. doi: 10.1016/j.cgh.2019.11.030. [Epub ahead of print]

PMID:
31756444
11.

Socioeconomic status differs between breast cancer patients treated with mastectomy and breast conservation, and affects patient-reported preoperative information.

Frisell A, Lagergren J, Halle M, de Boniface J.

Breast Cancer Res Treat. 2020 Feb;179(3):721-729. doi: 10.1007/s10549-019-05496-2. Epub 2019 Nov 18.

PMID:
31735998
12.

Surgical and Surgeon-Related Factors Related to Long-Term Survival in Esophageal Cancer: A Review.

Markar SR, Lagergren J.

Ann Surg Oncol. 2020 Mar;27(3):718-723. doi: 10.1245/s10434-019-07966-9. Epub 2019 Nov 5. Review.

PMID:
31691111
13.

Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men.

Xie SH, Ness-Jensen E, Rabbani S, Langseth H, Gislefoss RE, Mattsson F, Lagergren J.

Am J Gastroenterol. 2020 Feb;115(2):216-223. doi: 10.14309/ajg.0000000000000446.

PMID:
31658123
14.

Population-based study of anastomotic stricture rates after minimally invasive and open oesophagectomy for cancer.

Helminen O, Kytö V, Kauppila JH, Gunn J, Lagergren J, Sihvo E.

BJS Open. 2019 Jun 10;3(5):634-640. doi: 10.1002/bjs5.50176. eCollection 2019 Oct.

15.

Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.

Zheng J, Xie SH, Santoni G, Lagergren J.

Br J Cancer. 2019 Nov;121(10):877-882. doi: 10.1038/s41416-019-0598-z. Epub 2019 Oct 8.

PMID:
31591459
16.

Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.

Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J.

Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32721. [Epub ahead of print]

PMID:
31583704
17.

Peptic ulcer disease.

Sverdén E, Agréus L, Dunn JM, Lagergren J.

BMJ. 2019 Oct 2;367:l5495. doi: 10.1136/bmj.l5495. Review. No abstract available.

PMID:
31578179
18.

The Prognostic Role of Pre-operative Positron Emission Tomography-Computed Tomography and Endoscopic Ultrasound Parameters in Oesophageal Adenocarcinoma.

Dellaportas D, Zylstra J, Gossage J, Baker C, Kelly M, Hemelrijck MV, Griffin N, Lagergren J, Davies AR.

Chirurgia (Bucur). 2019 Jul-Aug;114(4):443-450. doi: 10.21614/chirurgia.114.4.443.

19.

Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer.

Brusselaers N, Lagergren J, Engstrand L.

Cancer Epidemiol. 2019 Oct;62:101585. doi: 10.1016/j.canep.2019.101585. Epub 2019 Aug 21.

PMID:
31445426
20.

Adherence to clinical guidelines for Barrett's esophagus.

Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J.

Scand J Gastroenterol. 2019 Aug;54(8):945-952. doi: 10.1080/00365521.2019.1641740. Epub 2019 Jul 17.

PMID:
31314608
21.

Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.

Mourikis TP, Benedetti L, Foxall E, Temelkovski D, Nulsen J, Perner J, Cereda M, Lagergren J, Howell M, Yau C, Fitzgerald RC, Scaffidi P; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Ciccarelli FD.

Nat Commun. 2019 Jul 15;10(1):3101. doi: 10.1038/s41467-019-10898-3.

22.

Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms.

Holmberg D, Santoni G, Xie S, Lagergren J.

Aliment Pharmacol Ther. 2019 Jul;50(2):159-166. doi: 10.1111/apt.15274. Epub 2019 Jun 4.

PMID:
31165515
23.

Reply to: Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a western population.

Doorakkers E, Lagergren J, Engstrand L, Brusselaers N.

Gut. 2019 May 21. pii: gutjnl-2019-319000. doi: 10.1136/gutjnl-2019-319000. [Epub ahead of print] No abstract available.

PMID:
31113849
24.

Prediabetes and diabetes in relation to risk of gastric adenocarcinoma.

Zheng J, Rutegård M, Santoni G, Wallner B, Johansson I, Sund M, Xie SH, Lagergren J.

Br J Cancer. 2019 Jun;120(12):1147-1152. doi: 10.1038/s41416-019-0470-1. Epub 2019 May 7.

PMID:
31061455
25.

Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study.

Kauppila JH, Tao W, Santoni G, von Euler-Chelpin M, Lynge E, Tryggvadóttir L, Ness-Jensen E, Romundstad P, Pukkala E, Lagergren J.

Gastroenterology. 2019 Jul;157(1):119-127.e1. doi: 10.1053/j.gastro.2019.03.048. Epub 2019 Mar 30.

PMID:
30940524
27.

Annual hospital volume of surgery for gastrointestinal cancer in relation to prognosis.

Gottlieb-Vedi E, Mattsson F, Lagergren P, Lagergren J.

Eur J Surg Oncol. 2019 Oct;45(10):1839-1846. doi: 10.1016/j.ejso.2019.03.016. Epub 2019 Mar 15.

PMID:
30904243
28.

Preoperative esophageal stenting and short-term outcomes of surgery for esophageal cancer in a population-based study from Finland and Sweden.

Helminen O, Kauppila JH, Kytö V, Gunn J, Lagergren J, Sihvo E.

Dis Esophagus. 2019 Dec 30;32(11). pii: doz005. doi: 10.1093/dote/doz005.

PMID:
30855081
29.

Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis.

Gottlieb-Vedi E, Kauppila JH, Malietzis G, Nilsson M, Markar SR, Lagergren J.

Ann Surg. 2019 Dec;270(6):1005-1017. doi: 10.1097/SLA.0000000000003252.

PMID:
30817355
30.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2227-2235.e1. doi: 10.1016/j.cgh.2019.01.041. Epub 2019 Feb 1.

PMID:
30716477
31.

Cohort profile: the Swedish Prescribed Drugs and Health Cohort (SPREDH).

Xie SH, Santoni G, Mattsson F, Ness-Jensen E, Lagergren J.

BMJ Open. 2019 Jan 28;9(1):e023155. doi: 10.1136/bmjopen-2018-023155.

32.

Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.

Kilander C, Lagergren J, Konings P, Sadr-Azodi O, Brusselaers N.

Acta Oncol. 2019 Mar;58(3):290-295. doi: 10.1080/0284186X.2018.1549367. Epub 2019 Jan 18.

PMID:
30656997
33.

Prediction of individuals at high absolute risk of esophageal squamous cell carcinoma.

Wang QL, Lagergren J, Xie SH.

Gastrointest Endosc. 2019 Apr;89(4):726-732.e2. doi: 10.1016/j.gie.2018.10.025. Epub 2018 Oct 25.

PMID:
30616974
34.

A population-based cohort study examining the risk of abdominal cancer after endovascular abdominal aortic aneurysm repair.

Markar SR, Vidal-Diez A, Sounderajah V, Mackenzie H, Hanna GB, Thompson M, Holt P, Lagergren J, Karthikesalingam A.

J Vasc Surg. 2019 Jun;69(6):1776-1785.e2. doi: 10.1016/j.jvs.2018.09.058. Epub 2018 Dec 21.

PMID:
30583890
35.

Risk factors for oesophageal cancer.

Xie SH, Lagergren J.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:3-8. doi: 10.1016/j.bpg.2018.11.008. Epub 2018 Nov 22. Review.

PMID:
30551854
36.

Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England.

Markar SR, Arhi C, Wiggins T, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003131. [Epub ahead of print]

37.

Outcomes of nutritional jejunostomy in the curative treatment of esophageal cancer.

Klevebro F, Johar A, Lagergren J, Lagergren P.

Dis Esophagus. 2019 Jul 1;32(7). pii: doy113. doi: 10.1093/dote/doy113.

PMID:
30496419
38.

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial.

Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A.

Ann Oncol. 2018 Dec 1;29(12):2356-2362. doi: 10.1093/annonc/mdy407.

39.

Clinical prediction model for tumor progression in Barrett's esophagus.

Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J.

Surg Endosc. 2019 Sep;33(9):2901-2908. doi: 10.1007/s00464-018-6590-5. Epub 2018 Nov 19.

40.

Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.

Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J.

JAMA Oncol. 2018 Nov 1;4(11):1576-1582. doi: 10.1001/jamaoncol.2018.3054. Retraction in: JAMA Oncol. 2019 May 1;5(5):744-745.

41.

Acute upper gastrointestinal bleeding.

Sverdén E, Markar SR, Agreus L, Lagergren J.

BMJ. 2018 Oct 25;363:k4023. doi: 10.1136/bmj.k4023. No abstract available.

PMID:
30361444
42.

Surgeon Volume and Surgeon Age in Relation to Proficiency Gain Curves for Prognosis Following Surgery for Esophageal Cancer.

Gottlieb-Vedi E, Mackenzie H, van Workum F, Rosman C, Lagergren P, Markar S, Lagergren J.

Ann Surg Oncol. 2019 Feb;26(2):497-505. doi: 10.1245/s10434-018-6869-8. Epub 2018 Oct 15.

43.

Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer Treatment.

Lohmander F, Lagergren J, Roy PG, Johansson H, Brandberg Y, Eriksen C, Frisell J.

Ann Surg. 2019 May;269(5):836-841. doi: 10.1097/SLA.0000000000003054.

PMID:
30308615
44.

ASO Author Reflections: Survival Trends in Gastric Adenocarcinoma.

Asplund J, Lagergren J.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):723-724. doi: 10.1245/s10434-018-6844-4. Epub 2018 Oct 8. No abstract available.

45.

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.

Kunzmann AT, Cañadas Garre M, Thrift AP, McMenamin ÚC, Johnston BT, Cardwell CR, Anderson LA, Spence AD, Lagergren J, Xie SH, Smyth LJ, McKnight AJ, Coleman HG.

Gastroenterology. 2019 Jan;156(1):43-45. doi: 10.1053/j.gastro.2018.09.038. Epub 2018 Sep 19.

PMID:
30243622
46.

Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.

Kauppila JH, Wahlin K, Lagergren P, Lagergren J.

Int J Cancer. 2019 Mar 15;144(6):1284-1291. doi: 10.1002/ijc.31840. Epub 2018 Oct 31.

PMID:
30168595
47.

Population-based cohort study of diabetes mellitus and mortality in gastric adenocarcinoma.

Zheng J, Xie SH, Santoni G, Lagergren J.

Br J Surg. 2018 Dec;105(13):1799-1806. doi: 10.1002/bjs.10930. Epub 2018 Jul 27.

PMID:
30051463
48.

The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.

Markar SR, Arhi C, Leusink A, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB.

Ann Surg. 2018 Nov;268(5):861-867. doi: 10.1097/SLA.0000000000002890.

49.

Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma.

Davies AR, Myoteri D, Zylstra J, Baker CR, Wulaningsih W, Van Hemelrijck M, Maisey N, Allum WH, Smyth E, Gossage JA, Lagergren J, Cunningham D, Green M; Guy's and St Thomas' Oesophago-Gastric Research Group and PROGRESS Study Group.

Br J Surg. 2018 Nov;105(12):1639-1649. doi: 10.1002/bjs.10900. Epub 2018 Jul 26.

PMID:
30047556
50.

The population-based incidence and mortality of biliary tract cancer in Sweden.

Kilander C, Lagergren J, Ljung R, Sadr-Azodi O.

Cancer Epidemiol. 2018 Oct;56:14-20. doi: 10.1016/j.canep.2018.06.004. Epub 2018 Jul 17.

PMID:
30025250

Supplemental Content

Loading ...
Support Center